Among the biggest mistakes Trump has made since returning to office is binding himself to Big Pharma. This avaricious, parasitical industry prioritizes profit over safety and helped precipitate one of history’s most calamitous mass-casualty events. Even now, in 2026, despite extensive evidence that the COVID-19 “clot shots” killed or maimed millions, Trump continues to tout Operation Warp Speed as one of his signature achievements. The lesson remains unlearned. As the old saying goes: Fool me once, shame on you; fool me twice, shame on me.
On Tuesday, Trump’s Food and Drug Administration quietly approved Moderna’s mRNA influenza vaccine for adults over 50—roughly 125 million Americans according to the 2020 census (though the precise number still alive after the clot-shot era is impossible to know).
Even the administration’s most prominent vaccine skeptic, HHS Secretary Robert F. Kennedy Jr., and CMS Administrator Dr. Mehmet Oz reportedly urged acting FDA Commissioner Kyle Diamantas to green-light the shot after reviewing a spreadsheet of Moderna’s Phase 1, 2, and 3 trial results, according to an administration source who spoke with Real Raw News.
As expected, Moderna’s reports overflowed with self-praise and claimed “irrefutable clinical proof” that none of its 22,502 trial participants suffered illnesses or post-vaccination complications. Moderna made essentially the same claim before the FDA granted emergency use authorization for its COVID-19 vaccine on December 18, 2020, for people 18 and older.
We remember how that turned out: deaths blamed on a virus less lethal than seasonal flu; mobile crematoriums collecting bodies from nursing homes; corpses fed into incinerators; autopsies of gunshot and traffic fatalities attributed to COVID-19; and the systematic smearing and cancellation of physicians who questioned vaccine efficacy or recommended alternatives such as ivermectin.
Now we face clot-shot redux—another DNA-altering mRNA product that could potentially kill or sicken millions who show up at pharmacies and doctors’ offices for their annual flu shots.
To be fair, RRN has not reviewed Moderna’s complete trial data, nor have we spoken with any of the participants. Has the company reformed? Has it finally produced a product free of serious harm that actually helps people with influenza? We are skeptical. The truth will become clearer once the seasonal shots begin entering arms in late September.
Personal note: mRNA technology remains a potential death sentence. I choose to remain pureblood.